Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Stem Cells and Development|June 10, 2004
Maintenance therapy with interferon-alpha 2b, cyclophosphamide, and prednisone in aggressive diffuse large cell lymphomaAgustin Avilés, Natividad Neri, M Jesús Nambo, et al.Cancer Biotherapy & Radiopharmaceuticals|December 27, 2007
Interferon and low dose methotrexate improve outcome in refractory mycosis fungoides/Sézary syndromeAgustin Avilés, M Jesús Nambo, Natividad Neri, et al.Cancer Biotherapy & Radiopharmaceuticals|February 17, 2009
Rituximab and chemotherapy in primary gastric lymphomaAgustin Avilés, Claudia Castañeda, Sergio Cleto, et al.Chemosphere|October 17, 2021
Caffeine photocatalytic degradation using composites of NiO/TiO<sub>2</sub>-F and CuO/TiO<sub>2</sub>-F under UV irradiationClaudia Castañeda, José J Martínez, Laura Santos, et al.Accident; Analysis and Prevention|October 30, 2020
WITHDRAWN: Temperature effects on meristem differentiation and flowering date in tuberose (Agave amica L.)Javier C Fragoso-Jimenez, Jaime Silva-Morales, Rodrigo Barba-Gonzalez, et al.Investigational New Drugs|September 1, 2005
Novel therapy in multiple myelomaAgustin Avilés, Natividad Neri, M Jesús Nambo, et al.Medical Oncology (Northwood, London, England)|February 6, 2008
Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecifiedAgustin Avilés, Claudia Castañeda, Natividad Neri, et al.Medical Oncology (Northwood, London, England)|October 1, 2004
Intensive chemotherapy in the treatment of aggressive diffuse large B-cell lymphoma: malignant lymphomaAgustin Avilés, M Jesús Nambo, Natividad Neri, et al.Cancer Biotherapy & Radiopharmaceuticals|June 30, 2007
Rituximab and escalated chemotherapy in elderly patients with aggressive diffuse large-cell lymphoma: a controlled clinical trialAgustin Avilés, María Jesus Nambo, Claudia Castañeda, et al.Leukemia & Lymphoma|September 14, 2004
Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcomeAgustin Avilés, Raúl Fernándezb, Felipe Pérez, et al.Pageof 3